Pharmather Holdings Stock Profit Margin
| PHRRF Stock | USD 0.15 0.01 7.14% |
Pharmather Holdings fundamentals help investors to digest information that contributes to Pharmather Holdings' financial success or failures. It also enables traders to predict the movement of Pharmather OTC Stock. The fundamental analysis module provides a way to measure Pharmather Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmather Holdings otc stock.
Pharmather |
Pharmather Holdings OTC Stock Profit Margin Analysis
Pharmather Holdings' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Pharmather Holdings has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Pharmather Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmather Holdings' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Pharmather Holdings could also be used in its relative valuation, which is a method of valuing Pharmather Holdings by comparing valuation metrics of similar companies.Pharmather Holdings is currently under evaluation in profit margin category among its peers.
Pharmather Fundamentals
| Return On Equity | -0.63 | |||
| Return On Asset | -0.25 | |||
| Current Valuation | (3.24 M) | |||
| Shares Outstanding | 88.17 M | |||
| Shares Owned By Insiders | 18.67 % | |||
| Shares Owned By Institutions | 0.06 % | |||
| Price To Earning | 2.26 X | |||
| Price To Book | 0.57 X | |||
| EBITDA | (4.1 M) | |||
| Net Income | (4.01 M) | |||
| Cash And Equivalents | 10.15 M | |||
| Cash Per Share | 0.12 X | |||
| Current Ratio | 70.26 X | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | (3.51 M) | |||
| Earnings Per Share | (0.04) X | |||
| Beta | 2.98 | |||
| Market Capitalization | 13.44 M | |||
| Total Asset | 12.16 M | |||
| Net Asset | 12.16 M |
About Pharmather Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmather Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmather Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmather Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Pharmather OTC Stock
Pharmather Holdings financial ratios help investors to determine whether Pharmather OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmather with respect to the benefits of owning Pharmather Holdings security.